Intuitive Surgical’s Next Growth Engine Is Hiding in Plain Sight—ASCs Are the REAL Catalyst!

Intuitive Surgical, a leader in robotic-assisted surgery, delivered a robust financial performance in 2025, driven by strong growth across multiple platforms, including da Vinci and Ion. The company’s revenue rose by 21% year-over-year, reaching $10.1 billion, supported by a substantial increase in procedures and system placements. Despite facing tariffs and a mixed effect from newer platforms impacting costs, Intuitive Surgical managed to uphold an operating margin of 37% through cost efficiency measures and strategic investments in R&D and manufacturing scale. In 2025, the company observed a significant 19% growth in total procedures, with the da Vinci’s single-port procedures contributing immensely to this increase. The U.S. market experienced a 15% growth in da Vinci procedures, exceeding 2 million, while international markets displayed remarkable expansion with a 23% rise, underscoring the global demand for minimally invasive surgeries.